Beranda › Adenokarsinoma Esofagus › Michigan › Ann Arbor
Uji klinis Adenokarsinoma Esofagus di Ann Arbor, MI
7 studi untuk Adenokarsinoma Esofagus mencari peserta di lokasi sekitar Ann Arbor (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
Menerima pesertaFase 2/3
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi jauhnya
- Chelsea Hospital, Chelsea · 15 mi jauhnya
- dan 3 lainnya
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Menerima pesertaFase 3
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · 7 mi jauhnya
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi jauhnya
- dan 4 lainnya
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
Menerima pesertaFase 1/2
- University of Michigan, Ann Arbor
Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus
Menerima pesertaFase 2
- University of Michigan Rogel Cancer Center, Ann Arbor
Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia
Menerima peserta
- University of Michigan, Ann Arbor
Obeticholic Acid for Prevention in Barrett's Esophagus
Menerima pesertaFase 2
- University of Michigan Rogel Cancer Center, Ann Arbor
A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer
Menerima pesertaFase 2
- VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor
Uji klinis Adenokarsinoma Esofagus di kota lain
- New York City, NY18 studi
- Boston, MA13 studi
- Houston, TX12 studi
- Nashville, TN11 studi
- Arlington, VA11 studi
- Durham, NC10 studi
- Rochester, MN9 studi
- Baldwin Park, CA9 studi
- St. Louis, MO9 studi
- Jacksonville, FL9 studi
- Queens, NY9 studi
- Los Angeles, CA9 studi
Studi lain di Ann Arbor
- Kanker Payudara27 studi
- Kanker Prostat27 studi
- Kanker Paru Non-Sel Kecil26 studi
- Kanker (semua jenis)25 studi
- Kanker Paru23 studi
- Kanker Kolorektal23 studi
- Gagal Jantung22 studi
- Leukemia Mieloid Akut17 studi
- Penyakit Kardiovaskular16 studi
- Kanker Pankreas14 studi
- Melanoma12 studi
- Stroke12 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.